Erden Zeynep
ETH Zurich, Department of Management, Technology and Economics, Weinbergstrasse 56/58, 8092 Zurich, Switzerland.
Drug Discov Today. 2017 Jan;22(1):5-9. doi: 10.1016/j.drudis.2016.09.002. Epub 2016 Sep 12.
Firms in the biopharmaceutical industry send signals to investors about the value of their knowledge by disclosing it in the form of patents and publications. In this way, they can gain reputation even before having products on the market. This paper compares the patenting and publishing activities of university spinoffs with other biopharmaceutical firms. The findings suggest that successful university spinoffs and successful other firms (not university spinoffs) tend to follow different knowledge disclosure strategies. Whereas successful university spinoffs tend to emphasize the scientific value of their knowledge and gain reputation through their high-quality publications, other successful firms tend to emphasize the commercial value of their knowledge and gain reputation through high-quality patents.
生物制药行业的公司通过以专利和出版物的形式披露知识，向投资者传递其知识价值的信号。通过这种方式，它们甚至在产品上市之前就能获得声誉。本文比较了大学衍生企业与其他生物制药公司的专利申请和出版活动。研究结果表明，成功的大学衍生企业和成功的其他公司（非大学衍生企业）倾向于采用不同的知识披露策略。成功的大学衍生企业倾向于强调其知识的科学价值，并通过高质量的出版物获得声誉，而其他成功的公司则倾向于强调其知识的商业价值，并通过高质量的专利获得声誉。
